Hugtakasafn þýðingamiðstöðvar utanríkisráðuneytisins
Hugtakasafn : Eitt hugtak
- ÍSLENSKA
- prótínmengjafræðilegur
- ENSKA
- proteomic
- Svið
- lyf
- Dæmi
-
[is]
Önnur tiltæk gögn: Tiltæk gögn vegna nýrra aðferða og líkana, þ.m.t. úr áhættumati, byggðu á eiturhrifaferlum, úr rannsóknum í glasi og lífmengjafræðilegum (t.d. genamengjafræðilegum, prótínmengjafræðilegum og umbrotsefnamengjafræðilegum) rannsóknum (e. omic studies), kerfislíffræði, tölvufræðilegri eiturefnafræði, lífupplýsingafræði og afkastamikilli skimun, skulu lögð fram samhliða
- [en] Other available data: Available data from emerging methods and models, including toxicity pathway-based risk assessment, in vitro and omic (genomic, proteomic, metabolomic, etc.) studies, systems biology, computational toxicology, bioinformatics, and high-throughput screening shall be submitted in parallel
- Skilgreining
- [en] proteomics is the large-scale study of proteins, particularly their structures and functions.[1][2] Proteins are vital parts of living organisms, as they are the main components of the physiological metabolic pathways of cells. The term "proteomics" (prótínmengjafræði) was first coined in 1997[3] to make an analogy with genomics, the study of the genes.
The word "proteome" (prótínmengi) is a blend of "protein" and "genome", and was coined by Marc Wilkins in 1994 while working on the concept as a PhD student.[4][5] The proteome is the entire complement of proteins,[4] including the modifications made to a particular set of proteins, produced by an organism or system. This will vary with time and distinct requirements, or stresses, that a cell or organism undergoes. Proteomics is an interdisciplinary formed on the basis of the research and development of the Human Genome Project, is also an emerging scientific research and exploration of the proteome research from the overall level of intracellular protein composition, structure, and its own unique activity patterns. It is an important component of functional genomics (Wikipedia) - Rit
-
[is]
Reglugerð Evrópuþingsins og ráðsins (ESB) nr. 528/2012 frá 22. maí 2012 um að bjóða sæfivörur fram á markaði og um notkun þeirra
- [en] Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products
- Skjal nr.
- 32012R0528
- Orðflokkur
- lo.
Takk fyrir
Ábendingin verður notuð til að bæta gæði þjónustu og upplýsinga á vef Stjórnarráðsins. Hikaðu ekki við að hafa samband ef þig vantar aðstoð.